The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
The Management of Depression During Pregnancy: A Report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists
Open accessAbstract
OBJECTIVE: To address the maternal and neonatal risks of both depression and antidepressant exposure and develop algorithms for periconceptional and antenatal management. METHOD: Representatives from the American Psychiatric Association, the American College of Obstetricians and Gynecologists and a consulting developmental pediatrician collaborated to review English language articles on fetal and neonatal outcomes associated with depression and antidepressant treatment during childbearing. Articles were obtained from Medline searches and bibliographies. Search keywords included pregnancy, pregnancy complications, pregnancy outcomes, depressive disorder, depressive disorder/dt, abnormalities/drug-induced/epidemiology, abnormalities/drug-induced/et. Iterative draft manuscripts were reviewed until consensus was achieved. RESULTS: Both depressive symptoms and antidepressant exposure are associated with fetal growth changes and shorter gestations, but the majority of studies that evaluated antidepressant risks were unable to control for the possible effects of a depressive disorder. Short-term neonatal irritability and neurobehavioral changes are also linked with maternal depression and antidepressant treatment. Several studies report fetal malformations in association with first trimester antidepressant exposure but there is no specific pattern of defects for individual medications or class of agents. The association between paroxetine and cardiac defects is more often found in studies that included all malformations rather than clinically significant malformations. Late gestational use of selective serotonin reuptake inhibitor antidepressants is associated with transitory neonatal signs and a low risk for persistent pulmonary hypertension in the newborn. Psychotherapy alone is an appropriate treatment for some pregnant women; however, others prefer pharmacotherapy or may require pharmacological treatment. CONCLUSIONS: Antidepressant use in pregnancy is well studied, but available research has not yet adequately controlled for other factors that may influence birth outcomes including maternal illness or problematic health behaviors that can adversely affect pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Disparities in Rates of Unintended Pregnancy In the United States, 1994 and 2001
Finer, L. B., & Henshaw, S. K. (2006) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3809006 · Cited by 1,557
Births: preliminary data for 2012.
Hamilton, B. E., Martin, J. A., & Ventura, S. J. (2013) · PubMed · Cited by 1,509
Gaynes, B. N., Gavin, N., Meltzer-Brody, S., Lohr, K. N., Swinson, T., Gartlehner, G., Brody, S., & Miller, W. C. (2005) · PsycEXTRA Dataset · doi:10.1037/e439372005-001 · Cited by 1,211
Cohen, L. S. (2006) · JAMA · doi:10.1001/jama.295.5.499 · Cited by 1,031
Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
Chambers, C. D., Hernandez-Diaz, S., Van Marter, L. J., Werler, M. M., Louik, C., Jones, K. L., & Mitchell, A. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052744 · Cited by 880
Spitzer, R. L., Williams, J. B. W., Kroenke, K., Hornyak, R., & McMurray, J. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106580 · Cited by 847
Birth Outcomes in Pregnant Women Taking Fluoxetine
Chambers, C. D., Johnson, K. A., Dick, L. M., Felix, R. J., & Jones, K. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351402 · Cited by 735
Prenatal depression effects on the fetus and newborn: a review
Field, T., Diego, M., & Hernandez-Reif, M. (2006) · Infant Behavior and Development · doi:10.1016/j.infbeh.2006.03.003 · Cited by 592
Neurodevelopment of Children Exposed in Utero to Antidepressant Drugs
Nulman, I., Rovet, J., Stewart, D. E., Wolpin, J., Gardner, H. A., Theis, J. G. W., Kulin, N., & Koren, G. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701233360404 · Cited by 573
Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.898 · Cited by 551
Matthey, S., Henshaw, C., Elliott, S., & Barnett, B. (2006) · Archives of Women's Mental Health · doi:10.1007/s00737-006-0152-x · Cited by 544
First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
Louik, C., Lin, A. E., Werler, M. M., Hernández-Díaz, S., & Mitchell, A. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067407 · Cited by 500
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
Alwan, S., Reefhuis, J., Rasmussen, S. A., Olney, R. S., & Friedman, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066584 · Cited by 495 · cited 3×
“While some linked database reports find that compared to unexposed offspring, those exposed to paroxetine during the first trimester are at higher risk of cardiac malformations [18,39,40], these results are disputed by other reports including several large case cohort studies [37,38].”
The impact of maternal depression in pregnancy on early child development
Deave, T., Heron, J., Evans, J., & Emond, A. (2008) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01752.x · Cited by 479 · cited 1×
“One large cohort study attempted to assess the specific effects of depressive symptoms, according to the Edinburgh Postnatal Depression Scale (EPDS), in mothers during pregnancy although child performance was based upon maternal report only and potential bias cannot be excluded [16].”
Increasing use of antidepressants in pregnancy
Cooper, W. O., Willy, M. E., Pont, S. J., & Ray, W. A. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.01.033 · Cited by 458
Nulman, I., Rovet, J., Stewart, D. E., Wolpin, J., Pace-Asciak, P., Shuhaiber, S., & Koren, G. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1889 · Cited by 441
Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.5.592 · Cited by 434
Kulin, N. A., Pastuszak, A., Sage, S. R., Schick-Boschetto, B., Spivey, G., Feldkamp, M., Ormond, K., Matsui, D., Stein-Schechman, A. K., Cook, L., et al. (1998) · JAMA · doi:10.1001/jama.279.8.609 · Cited by 424
Self-reported depression and negative pregnancy outcomes
Steer, R. A., Scholl, T. O., Hediger, M. L., & Fischer, R. L. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90149-h · Cited by 403
Management of bipolar disorder during pregnancy and the postpartum period
Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., Manber, R., Viguera, A., Suppes, T., & Altshuler, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.608 · Cited by 394
Maternal psychological distress during pregnancy in relation to child development at age two
DiPietro, J. A., Novak, M. F. S. X., Costigan, K. A., Atella, L. D., & Reusing, S. P. (2006) · Child Development · doi:10.1111/j.1467-8624.2006.00891.x · Cited by 390
Outcomes of Prenatal Antidepressant Exposure
Simon, G. E., Cunningham, M. L., & Davis, R. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2055 · Cited by 386
Spinelli, M. G., & Endicott, J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.555 · Cited by 379
Pregnancy Outcome Following First-Trimester Exposure to Fluoxetine (Prozac)
Pastuszak, A. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500170076037 · Cited by 368
Orr, S. T. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf131 · Cited by 357
Perinatal Psychiatry: Use and Misuse of the Edinburgh Postnatal Depression Scale
Worley, L. (2001) · Psychosomatics · doi:10.1176/appi.psy.42.5.446 · Cited by 344
Laine, K., Heikkinen, T., Ekblad, U., & Kero, P. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.720 · Cited by 331
Neonate Characteristics After Maternal Use of Antidepressants in Late Pregnancy
Källén, B. (2004) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.158.4.312 · Cited by 300
Neonatal Outcome following Maternal Antenatal Depression and Anxiety: A Population-based Study
Andersson, L. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh122 · Cited by 294
Maternal Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Newborn Neurobehavior
Zeskind, P. S., & Stephens, L. E. (2004) · Pediatrics · doi:10.1542/peds.113.2.368 · Cited by 280
Källén, B. A. J., & Otterblad Olausson, P. (2007) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20327 · Cited by 270
Perinatal Outcome Following Third Trimester Exposure to Paroxetine
Costei, A. M., Kozer, E., Ho, T., Ito, S., & Koren, G. (2002) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.156.11.1129 · Cited by 270
Pharmacologic Treatment of Depression During Pregnancy
Wisner, K. L. (1999) · JAMA · doi:10.1001/jama.282.13.1264 · Cited by 247
Suri, R., Altshuler, L., Hellemann, G., Burt, V. K., Aquino, A., & Mintz, J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06071172 · Cited by 247
Oberlander, T. F., Misri, S., Fitzgerald, C. E., Kostaras, X., Rurak, D., & Riggs, W. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0214 · Cited by 244
Einarson, A., Fatoye, B., Sarkar, M., Lavigne, S. V., Brochu, J., Chambers, C., Mastroiacovo, P., Addis, A., Matsui, D., Schuler, L., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1728 · Cited by 240
Selective serotonin reuptake inhibitors and adverse pregnancy outcomes
Wen, S. W., Yang, Q., Garner, P., Fraser, W., Olatunbosun, O., Nimrod, C., & Walker, M. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.02.019 · Cited by 234
Pregnancy outcome of women exposed to bupropion during pregnancy: A prospective comparative study
Chun-Fai-Chan, B., Koren, G., Fayez, I., Kalra, S., Voyer-Lavigne, S., Boshier, A., Shakir, S., & Einarson, A. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.09.027 · Cited by 234
Risks Associated With Selective Serotonin Reuptake Inhibitors in Pregnancy
Malm, H., Klaukka, T., & Neuvonen, P. J. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000187302.61812.53 · Cited by 211
Use of Electroconvulsive Therapy During Pregnancy
Miller, L. J. (1994) · Psychiatric Services · doi:10.1176/ps.45.5.444 · Cited by 211
Källén, B., & Olausson, P. O. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1570 · Cited by 205
Oberlander, T. F., Warburton, W., Misri, S., Riggs, W., Aghajanian, J., & Hertzman, C. (2008) · Birth Defects Research Part B: Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20144 · Cited by 187
Einarson, A., Pistelli, A., DeSantis, M., Malm, H., Paulus, W. D., Panchaud, Kennedy, D., Einarson, T. R., & Koren, G. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07060879 · Cited by 186
Antidepressant Use during Pregnancy and the Rates of Spontaneous Abortions: A Meta-Analysis
Hemels, M. E., Einarson, A., Koren, G., Lanctôt, K. L., & Einarson, T. R. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e547 · Cited by 179
Depression as a potential causal factor in subsequent miscarriage in recurrent spontaneous aborters
Sugiura‐Ogasawara, M., Furukawa, T. A., Nakano, Y., Hori, S., Aoki, K., & Kitamura, T. (2002) · Human Reproduction · doi:10.1093/humrep/17.10.2580 · Cited by 153
Psychological health in early pregnancy: relationship with nausea and vomiting
Swallow, B. L., Sw, L., Masson, E., & Hay, D. M. (2003) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610310001620251 · Cited by 151
Bupropion in pregnancy and the prevalence of congenital malformations
Cole, J. A., Modell, J. G., Haight, B. R., Cosmatos, I. S., Stoler, J. M., & Walker, A. M. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1296 · Cited by 149
Antidepressant drugs during pregnancy and infant congenital heart defect
Källén, B. A. J., & Olausson, P. O. (2006) · Reproductive Toxicology · doi:10.1016/j.reprotox.2005.11.006 · Cited by 149
Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children
Headley, J., Northstone, K., Simmons, H., Golding, J., & and the ALSPAC Study Team (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0775-7 · Cited by 142
Einarson, A., Bonari, L., Lavigne, S. V., Addis, A., Matsui, D. M., Johnson, Y., & Koren, G. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800207 · Cited by 139
Exposure to Mirtazapine During Pregnancy
Djulus, J., Koren, G., Einarson, T. R., Wilton, L., Shakir, S., Diav‐Citrin, O., Kennedy, D. A., Lavigne, S. V., Santis, M. D., & Einarson, A. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0817 · Cited by 138
Oberlander, T. F., Warburton, W. P., Misri, S. K., Aghajanian, J., & Hertzman, C. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.037101 · Cited by 134
Delivery Outcome in Relation to Maternal Use of Some Recently Introduced Antidepressants
Lennestål, R., & Källén, B. A. J. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815ac4d2 · Cited by 128
Citalopram use in pregnancy: Prospective comparative evaluation of pregnancy and fetal outcome
Sivojelezova, A., Shuhaiber, S., Sarkissian, L., Einarson, A., & Koren, G. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.05.012 · Cited by 128
Estimates of the Annual Number of Clinically Recognized Pregnancies in the United States, 1981-1991
Saraiya, M., Berg, C. J., Shulman, H., Green, C., & Atrash, H. K. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009747 · Cited by 127
Tricyclic dose requirements across pregnancy
Wisner, K. L., Perel, J. M., & Wheeler, S. B. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.10.1541 · Cited by 115
Psychological and social correlates of the onset of affective disorders among pregnant women
Kitamura, T., Shima, S., Sugawara, M., & Toda, M. A. (1993) · Psychological Medicine · doi:10.1017/s003329170002643x · Cited by 114
The Expert Consensus Guideline Series. Treatment of depression in women.
Altshuler, L. L., Cohen, L. S., Moline, M. L., Kahn, D. A., Carpenter, D., & Docherty, J. P. (2001) · PubMed · Cited by 113
Oberlander, T. F., Bonaguro, R. J., Misri, S. K., Papsdorf, M., Ross, C. J., & Simpson, E. M. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002007 · Cited by 112
Pulmonary hypertension in the newborn
Greenough, A., & Khetriwal, B. (2005) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2005.03.005 · Cited by 74
Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)
Pastuszak, A. L. (1993) · JAMA · doi:10.1001/jama.269.17.2246 · Cited by 72
Punamäki, R., Repokari, L., Vilska, S., Poikkeus, P., Tiitinen, A. E., Sinkkonen, J., & Tulppala, M. (2006) · Infant Behavior and Development · doi:10.1016/j.infbeh.2005.12.001 · Cited by 56
Nakano, Y., Oshima, M., Sugiura‐Ogasawara, M., Aoki, K., Kitamura, T., & Furukawa, T. A. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0047.2004.00273.x · Cited by 54
Birth Outcomes in Pregnant Women Taking Fluoxetine
Chambers, C., Johnson, K. D., Dick, L. M., Felix, R. J., & Jones, K. L. (1997) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199703000-00005 · Cited by 52
Nelson, D. B., Mcmahon, K., Joffe, M. M., & Brensinger, C. M. (2003) · Journal of Women s Health · doi:10.1089/154099903768248276 · Cited by 35
Electroconvulsive Therapy in Pregnancy
Pinette, M. G., Santarpio, C., Wax, J. R., & Blackstone, J. A. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000265588.79929.98 · Cited by 33
Increasing use of antidepressants in pregnancy
SHULMAN, L. P. (2008) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/s1090-798x(08)79180-x · Cited by 19
First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
&NA; (2008) · Survey of Anesthesiology · doi:10.1097/01.sa.0000296396.47671.99 · Cited by 16
Is Electroconvulsive Therapy in Pregnancy Safe?
RICHARDS, D. S. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000277540.63064.d3 · Cited by 15
Williams, K. E. (2008) · Yearbook of Neonatal and Perinatal Medicine · doi:10.1016/s8756-5005(08)79009-7 · Cited by 15
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
Dungan, J. S. (2008) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/s1090-798x(08)79028-3 · Cited by 5
Cited by
ACOG Committee Opinion No. 757: Screening for Perinatal Depression
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002927 · Cited by 771
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.
Kanes, S., Colquhoun, H., Gunduz-Bruce, H., Raines, S., Arnold, R., Schacterle, A., Doherty, J., Epperson, C. N., Deligiannidis, K. M., Riesenberg, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31264-3 · Cited by 479
Committee Opinion No. 630: Screening for Perinatal Depression
(2015) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000465192.34779.dc · Cited by 424
Palladino, C. L., Singh, V., Campbell, J., Flynn, H., & Gold, K. J. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31823294da · Cited by 313
ACOG Committee Opinion No. 762: Prepregnancy counseling
(2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003013 · Cited by 272
Metadata
- Venue
- Obstetrics & Gynecology
- Published
- 2009-09
- Volume
- 114
- Issue
- 3
- Pages
- 703-713
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2047601981
- Cited by
- 345
- References
- 71
- FWCI
- 24.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.